Since case-control studies have shown that patients with AD have a lower concentration of plasma amylin than controls19,33 and amylin aggregates are found in the AD brain,16 it is possible that an extremely high plasma amylin concentration declines owing to its aggregation and deposition in the brain during neurodegeneration processed in the brain occurring for longer than 10 years. Here, IAPP is linked to Alzheimer disease.